Disease Burden in the Context of Disasters: Insights from Over 6.7 million Respondents in the Bangladesh Disaster-Related Statistics of 2021.

Objectives: The objective of this study was to explore the burden of disasters and adverse health outcomes during and following disasters in Bangladesh.

Methods: We analyzed 6 788 947 respondents' data from a cross-sectional and nationally representative 2021 Bangladesh Disaster-related Statistics (BDRS). The key explanatory variables were the types of disasters respondents faced, while the outcome variables were the disease burden during and following disasters.

Predicting the potential impact of scaling up four pneumonia interventions on under-five pneumonia mortality: A prospective Lives Saved Tool (LiST) analysis for Bangladesh, Chad, and Ethiopia.

Background: Pneumonia remains the leading cause of mortality in under-five children outside the neonatal period. Progress has slowed down in the last decade, necessitating increased efforts to scale up effective pneumonia interventions.

Methods: We used the Lives Saved Tool (LiST), a modelling software for child mortality in low- and middle-income settings, to prospectively analyse the potential impact of upscaling pneumonia interventions in Bangladesh, Chad, and Ethiopia from 2023 to 2030.

Strain induced structural phase transition and compositional dependent magnetic phase transition in Ti doped BiBaFeO ceramics.

BiBaFeTiO ( ) samples are prepared using solid state reaction technique. Bi site is replaced with 20 % Ba which induced structural modification from rhombohedral to pseudo cubic accompanied by the creation of oxygen vacancies owing to the charge reimbursement. Fe site is replaced with different concentrations of Ti keeping Ba content fixed.

Management of fast breathing pneumonia in young infants aged 7 to 59 days by community level health workers: protocol for a multi-centre cluster randomized controlled trial.

Background: WHO does not recommend community-level health workers (CLHWs) using integrated community case management (iCCM) to treat 7-59 days old infants with fast breathing with oral amoxicillin, whereas World Health Organization (WHO) integrated management of childhood illness (IMCI) recommends it. We want to collect evidence to help harmonization of both protocols.

Methods: A cluster, randomized, open-label trial will be conducted in Africa and Asia (Ethiopia, Malawi, Bangladesh and India) using a common protocol with the same study design, inclusion criteria, intervention, comparison, and outcomes to contribute to the overall sample size.